Recombinant human activated protein C for the treatment of severe sepsis and septic shock: A study protocol for incorporating observational evidence using a Bayesian approach

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Zhang, Zhongheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; PROTEIN C; RECOMBINANT PROTEIN;

ADULT; AGE; BAYES THEOREM; HUMAN; MORTALITY; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SHOCK, SEPTIC;

ADULT; AGE FACTORS; BAYES THEOREM; HOSPITAL MORTALITY; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PROTEIN C; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SEPSIS; SHOCK, SEPTIC;

EID: 84905388045     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005622     Document Type: Article

References (28)

1. Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012;2:010404.
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10. (Pubitemid 32641789)
3. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-53. (Pubitemid 43145611)
4. Slade E, Tamber PS, Vincent JL. The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care (London, England) 2003;7:1-2. (Pubitemid 36204256)
5. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010;38:367-74.
6. Christiaans SC, Wagener BM, Esmon CT, et al. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 2013;305:L455-66.
7. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008;118:1294-303.
8. Marti-Carvajal AJ, Sola I, Gluud C, et al. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev 2012;12:CD004388.
9. Lai PS, Matteau A, Iddriss A, et al . An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock. Minerva Anestesiol 2013;79:33-43.
10. Kalil AC, LaRosa SP. Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression. Lancet Infect Dis 2012;12:678-86.
11. Chen MH, Ibrahim JG. Power prior distributions for regression models. Stat Sci 2000;15:46-60.
12. Prasad K, Jaeschke R, Wyer P, et al. Tips for teachers of evidence-based medicine: understanding odds ratios and their relationship to risk ratios. J Gen Intern Med 2008;23:635-40.
13. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-41. (Pubitemid 29009523)
14. Zhang Z, Xu X, Chen K. Lactate clearance as a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review study protocol. BMJ Open 2014;4:e004752-e.
15. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001;20:641-54. (Pubitemid 32166424)
16. Peters JL, Sutton AJ, Jones DR, et al. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295:676-80. (Pubitemid 43209069)
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
18. Egger M, Davey Smith G, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
19. Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008;61:991-6.
20. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002;21:1601-23. (Pubitemid 34746065)
21. Welton NJ, Sutton AJ, Cooper NJ, et al . Generalized evidence synthesis. Evidence synthesis for decision making in healthcare. 1st edn. Wiley, 2012:227-33.
22. Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008;61:64-75.
23. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75. (Pubitemid 38594143)
24. Angus DC. Drotrecogin alfa (activated)...a sad final fizzle to a roller-coaster party. Crit Care 2012;16:107.
25. Vincent J-L. We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 2010;38:S534-8.
26. Han S-H, Sevransky J. Another "negative" acute lung injury trial. Crit Care Med 2012;40:315-16.
27. Serpa Neto A, Cardoso SO, Manetta JA, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 2012;308:1651-9.
28. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 2001;10:277-303. (Pubitemid 32691157)